This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
, No Gclids
Disease Info Card
Cholesterol Ester Storage Disease
Information about Cholesterol Ester Storage Disease: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.
Overview of Cholesterol Ester Storage Disease
Most recent studies have shown that Cholesterol Ester Storage Disease shares some biological mechanisms with arteriosclerosis, atherosclerosis, fibrosis, gaucher-disease, hepatomegaly, hypercholesterolemia, hypercholesterolemia-familial, hyperlipidemia, hyperlipoproteinemia-type-iib, hyperlipoproteinemias, hypokinesia, lipoidosis, liver-cirrhosis, liver-diseases, lysosomal-storage-diseases, niemann-pick-diseases, storage-disease, wolman-disease, xanthomatosis.
Among the many pathways, these few ones have gauged particular interests from scientists studying Cholesterol Ester Storage Disease, and have been seen in publications frequently: Aging, Cholesterol Efflux, Cholesterol Homeostasis, Cholesterol Storage, Dna Amplification, Dna Repair, Endocytosis, Fatty Acid Oxidation, Glycosylation, Lipid Homeostasis, Lipid Storage, Localization, Pathogenesis, Receptor-mediated Endocytosis, Secretion, Translation, Transport, Urea Cycle
Quite a number of genes have been found to play important roles in Cholesterol Ester Storage Disease, such as ABCA1, APOA1, APOB, ATP7B, CEL, CES1, CETP, CTSA, GLB1, LDLR, LIPA, LIPF, LPL, PNLIP, SLC4A1, TG. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.
In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.